Skip to main content
    P

    Precipio Inc (PRPO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $22.54
    +0.29 (+1.30%)

    Market Cap: $40.44M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    39%(9/23)
    Avg Surprise
    -66.13%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.12N/AN/ABeat+79.6%
    Mar 26
    Reported May 19
    		$-0.81N/AN/ABeat-231.1%
    Sep 25
    Reported Nov 14
    		$-0.05N/AN/ABeat+88.2%
    Jun 25
    Reported Aug 13
    		$0.05N/AN/ABeat+106.0%
    Mar 25
    Reported May 14
    		$-0.59N/AN/ABeat-190.3%
    Dec 24
    Reported Mar 27
    		$-0.24N/A-133.03%Miss+76.5%
    Sep 24
    Reported Nov 6
    		$-0.42N/AN/ABeat+76.5%
    Jun 24
    Reported Aug 13
    		$-0.83N/AN/ABeat+67.9%
    Mar 24
    Reported May 14
    		$0.65$0.00N/ABeat+751.4%
    Sep 23
    Reported Nov 13
    		$-1.04$-1.40+25.71%Beat+62.9%
    Jun 23
    Reported Aug 11
    		$-1.80$-2.00+10.00%Beat+0.0%
    Mar 23
    Reported May 12
    		$-2.60$-2.60+0.00%Beat+35.0%
    Dec 22
    Reported Mar 30
    		$-0.10$-0.14+28.57%Beat-11.1%
    Sep 22
    Reported Nov 10
    		$-2.80$-0.80-250.00%Miss-75.0%
    Jun 22
    Reported Aug 11
    		$-1.80$-1.00-80.00%Miss+35.7%
    Mar 22
    Reported May 11
    		$-4.00$-1.00-300.00%Miss-150.0%
    Dec 21
    Reported Mar 30
    		$-0.09$-0.08-12.50%Miss+18.2%
    Sep 21
    Reported Nov 12
    		$-1.60$-2.00+20.00%Beat+61.9%
    Jun 21
    Reported Aug 12
    		$-2.80$-2.00-40.00%Miss+30.0%
    Mar 21
    Reported May 14
    		$-1.60$-2.00+20.00%Beat+87.4%
    Dec 20
    Reported Mar 29
    		$-0.11$-0.09-22.22%Miss+77.1%
    Sep 20
    Reported Nov 13
    		$-4.20$-4.00-5.00%Miss+32.3%
    Jun 20
    Reported Aug 13
    		$-4.00$-4.00+0.00%Beat+81.0%
    Mar 20
    Reported May 14
    		$-12.72$-3.60-253.33%Miss-2550.0%
    Dec 19
    Reported Mar 27
    		$-0.48$-0.17-182.35%Miss-108.7%
    Sep 19
    Reported Nov 13
    		$-6.20$-7.80+20.51%Beat-3547.1%
    Jun 19
    Reported Aug 9
    		$-21.00$-7.40-183.78%Miss-13900.0%
    Mar 19
    Reported Apr 16
    		$-0.48$-0.43-11.63%Miss-2.1%
    Dec 18
    Reported Feb 27
    		$-0.23N/A+65.67%Beat+81.3%
    Sep 18
    Reported Nov 19
    		$-0.17N/A-129.82%Miss+87.5%
    Jun 18
    Reported Aug 17
    		$-0.15N/A-107.77%Miss+99.0%
    Mar 18
    Reported Apr 13
    		$-0.47N/AN/ABeat+65.9%
    Dec 17
    Reported Feb 28
    		$-1.23N/AN/ABeat+96.1%
    Sep 17
    Reported Nov 20
    		$-1.36N/AN/ABeat-
    Jun 17
    Reported Aug 21
    		$-15.35N/AN/ABeat-
    Mar 17
    Reported Apr 13
    		$-1.38N/AN/ABeat-
    Dec 16
    Reported Mar 15
    		$-31.50N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA55.53x
    Price/FCF51.06xFCF Yield1.96%
    Profitability
    Profit Margin-4.47%Operating Margin-8.53%
    ROE-8.98%ROIC-6.11%
    Financial Health
    Debt/Equity0.02xInterest CoverageN/A
    Current Ratio1.77xQuick Ratio1.56x
    Trading Statistics
    Beta1.30Avg Volume75.06K
    52-Week High$33.6352-Week Low$16.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$23.04
    SMA 20$23.80
    SMA 50$25.51
    SMA 200$25.20
    EMA 10$23.01
    EMA 20$23.76
    EMA 50$24.67
    EMA 200$23.91

    MACD

    Line: -0.92Signal: -0.84Hist: -0.09

    ADX

    ADX: 31.2+DI: 9.7-DI: 24.2

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down92.0
    PSAR$23.94

    Bollinger Bands

    Upper Band$26.41
    Lower Band$21.19
    %B Position2192%(Upper)
    Band Width0.26

    RSI (14-Day)

    Neutral
    37.5

    Momentum Oscillators

    Stoch %K19.9
    Stoch %D16.9
    Williams %R-75.2
    ROC (10d)-0.8%
    Momentum-0.19
    CCI (20d)-103.6
    MFI (14d)46.4

    Volatility Measures

    ATR (14d)$1.25(5.5%)
    StdDev (20d)1.30
    Hist Vol45.5%(High)

    Volume Flow

    VWAP$22.45
    OBV-784.0K
    AD Line81.5K
    CMF (20d)0.205

    Volume Metrics

    Avg Vol (20d)60.3K
    Vol Ratio0.7x
    VWMA (20d)$24.50

    Pivot Points

    R3$23.92
    R2$23.54
    R1$22.90
    Pivot Point$22.52
    S1$21.88
    S2$21.50
    S3$20.86

    Advanced Oscillators

    TSI-22.93
    Ultimate Osc45.1
    KST-134.60

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$7.02M$6.71M$6.70M$6.77M$5.65M$4.93M$5.45M$5.21M$4.44M$3.43M$4.33M$4.52M
    Cost of Revenue$3.88M$3.99M$3.57M$3.76M$3.23M$2.79M$2.80M$2.93M$2.73M$2.51M$2.32M$2.63M
    Gross Profit$3.14M$2.73M$3.13M$3.00M$2.43M$2.14M$2.65M$2.28M$1.72M$920,000$2.01M$1.89M
    Operating Expenses$3.73M$4.15M$2.59M$3.07M$3.25M$3.00M$2.98M$2.87M$2.92M$2.99M$2.87M$3.33M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating Income$-599,000$-1,428,000$542,000$-61,000$-824,000$-859,000$-336,000$-597,000$-1,209,000$-2,074,000$-854,000$-1,448,000
    Interest Income$-9,000$-15,000$0$-9,000$-23,000$-25,000$0$-29,000$-11,000$0$0$0
    Interest Expense$0$15,000$16,000$18,000$0$25,000$29,000$29,000$11,000$5,000$6,000$7,000
    Income Before Tax$-219,000$-1,443,000$526,000$-79,000$74,000$-884,000$-365,000$-626,000$-1,220,000$-2,079,000$925,000$-1,455,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-219,000$-1,443,000$526,000$-79,000$74,000$-884,000$-365,000$-626,000$-1,220,000$-2,079,000$925,000$-1,455,000
    EBITDA$259,000$-970,000$1.02M$368,000$520,000$-442,000$47,000$-215,000$-836,000$-1,696,000$-483,000$-1,063,000
    EBIT$-210,000$-1,428,000$542,000$-70,000$97,000$-859,000$-336,000$-597,000$-1,209,000$-2,074,000$-854,000$-1,448,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRPO

    News

    Precipio reports USD 7.02 million Q2 revenue growth for stock investors

    Precipio reported a Q2 2026 revenue of USD 7.02 million, marking a 24.18% increase year over year, though it resulted in a diluted loss per share of USD 0.12. The company, focused on cancer diagnostics...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Precipio reports 50.60 percent revenue growth: what it means for Precipio stock

    Precipio (PRPO) reported a trailing-twelve-month revenue growth of 50.60 percent as of October 5, 2026, driven by a 24.18 percent year-over-year increase in second-quarter 2026 revenue to USD 7.02 million. Despite this...

    ad-hoc-news.de•10/13/26•Somewhat-Bullish

    PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

    This article compares two cancer diagnostics companies, Precipio, Inc. (PRPO) and Biodesix, Inc. (BDSX), to determine which offers a better investment opportunity. While both operate in the cancer diagnostics sector...

    Eastern Progress•10/8/26•Bullish

    Precipio stock falls 2.29 percent as Q2 revenue rises 24.18 percent

    Precipio stock (PRPO) fell 2.29% to USD 23.45 on October 6, 2026, despite a 24.18% year-over-year increase in Q2 revenue to USD 7.021 million. The company reported a diluted earnings per share loss of USD 0.12...

    AD HOC NEWS•10/6/26•Somewhat-Bearish

    The Technical Signals Behind (PRPO) That Institutions Follow

    This article analyzes the technical signals for Precipio Inc. (NASDAQ: PRPO), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It details three AI-generated trading strategies...

    Stock Traders Daily•10/5/26•Somewhat-Bullish

    PRPO Valuation and Fair Value

    Forward P/E
    15.4x
    EV/EBITDA
    55.5x
    P/FCF
    51.1x
    PEG
    0.0x
    P/B
    2.7x
    See GNG's fair value

    PRPO Profitability: Margins, ROIC and FCF

    Gross margin
    44.1%
    Operating margin
    -8.5%
    Net margin
    -4.5%
    ROIC
    -6.1%
    ROE
    -9.0%
    FCF margin
    2.9%
    FCF yield
    2.0%

    PRPO Competitors

    CompanyTicker
    Ekso Bionics Holdings IncEKSO
    Instil Bio Inc.TIL
    PureTech Health PLCPRTC
    Nano X Imaging LtdNNOX
    Tevogen Bio Holdings Inc.TVGN
    Grace Therapeutics, Inc.GRCE
    eXoZymes, Inc.EXOZ
    Scynexis IncSCYX

    Sector: Healthcare

    PRPO Bull Case vs Bear Case

    Bull case

    • PRPO grew quarterly revenue 24.2% year over year.

    Bear case

    • PRPO has a -4.5% net profit margin.

    PRPO Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -57.0%

    Frequently Asked Questions About PRPO

    Does PRPO pay dividends?

    Precipio Inc (PRPO) does not currently pay a regular dividend.

    What is PRPO's market cap?

    Precipio Inc (PRPO) has a market capitalization of $40.44M with a current stock price of $22.54.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In